Clinical Trials Insight: 700046615

Trial Profile

Clinical Trials Insight: 700046615

Not stated
Phase of Trial: Phase I

Latest Information Update: 17 Sep 2010

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Sponsors Teikoku Pharma USA
  • Most Recent Events

    • 17 Sep 2010 The USA FDA has accepted the New Drug Application for the weekly, transdermal patch formulation of donepezil (Aricept) for review, according to a Teikoku Pharma USA Inc media release.
    • 17 Sep 2010 The USA FDA has accepted for review the New Drug Application (NDA) for the weekly, transdermal patch formulation of donepezil, according to an Eisai Pharmaceuticals media release.
    • 10 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top